DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,456,225 | -3.9% | 13,713 | +1.2% | 0.66% | -7.0% |
| Q4 2022 | $3,595,114 | +2.1% | 13,545 | -0.7% | 0.70% | -7.5% |
| Q3 2022 | $3,522,000 | -48.8% | 13,635 | -49.7% | 0.76% | +7.6% |
| Q2 2022 | $6,876,000 | +44.4% | 27,120 | +67.1% | 0.71% | -15.4% |
| Q1 2022 | $4,762,000 | -6.4% | 16,233 | +5.0% | 0.84% | +2.1% |
| Q4 2021 | $5,085,000 | +4.5% | 15,455 | -3.3% | 0.82% | -12.4% |
| Q3 2021 | $4,867,000 | +8.3% | 15,987 | -4.5% | 0.94% | +8.2% |
| Q2 2021 | $4,493,000 | +5.1% | 16,743 | -11.8% | 0.86% | +0.5% |
| Q1 2021 | $4,275,000 | -0.9% | 18,992 | -2.2% | 0.86% | -8.1% |
| Q4 2020 | $4,313,000 | +2.6% | 19,413 | -0.5% | 0.94% | -10.4% |
| Q3 2020 | $4,202,000 | +7.8% | 19,516 | -11.5% | 1.05% | +7.5% |
| Q2 2020 | $3,899,000 | +34.1% | 22,048 | +5.0% | 0.97% | +10.4% |
| Q1 2020 | $2,907,000 | -19.2% | 21,003 | -10.4% | 0.88% | +6.8% |
| Q4 2019 | $3,598,000 | +6.3% | 23,442 | 0.0% | 0.82% | -0.8% |
| Q3 2019 | $3,386,000 | -1.0% | 23,442 | -2.1% | 0.83% | +1.6% |
| Q2 2019 | $3,421,000 | -49.5% | 23,939 | -53.3% | 0.82% | +2.2% |
| Q1 2019 | $6,770,000 | +20.5% | 51,278 | -5.9% | 0.80% | +9.7% |
| Q4 2018 | $5,620,000 | +89.0% | 54,498 | +99.1% | 0.73% | +16.1% |
| Q3 2018 | $2,974,000 | -44.8% | 27,373 | -49.9% | 0.63% | +5.7% |
| Q2 2018 | $5,392,000 | +3.1% | 54,640 | +2.2% | 0.60% | -2.1% |
| Q1 2018 | $5,232,000 | +1.7% | 53,438 | -3.6% | 0.61% | -0.3% |
| Q4 2017 | $5,146,000 | +114.3% | 55,446 | +98.1% | 0.61% | +8.2% |
| Q3 2017 | $2,401,000 | +0.8% | 27,994 | -0.9% | 0.56% | -1.6% |
| Q2 2017 | $2,383,000 | -0.9% | 28,235 | +0.4% | 0.57% | -3.0% |
| Q1 2017 | $2,404,000 | +3.0% | 28,110 | -6.3% | 0.59% | +6.1% |
| Q4 2016 | $2,334,000 | -1.5% | 29,985 | -0.8% | 0.56% | -4.1% |
| Q3 2016 | $2,370,000 | -25.3% | 30,235 | -3.8% | 0.58% | -28.4% |
| Q2 2016 | $3,173,000 | +4.8% | 31,420 | -1.6% | 0.81% | +2.0% |
| Q1 2016 | $3,029,000 | +0.9% | 31,935 | -1.2% | 0.80% | -0.4% |
| Q4 2015 | $3,001,000 | +7.4% | 32,310 | -1.4% | 0.80% | +8.0% |
| Q3 2015 | $2,793,000 | -2.1% | 32,778 | -1.7% | 0.74% | +12.3% |
| Q2 2015 | $2,854,000 | -13.0% | 33,343 | -13.7% | 0.66% | -11.8% |
| Q1 2015 | $3,281,000 | -1.8% | 38,643 | -0.9% | 0.75% | +7.2% |
| Q4 2014 | $3,342,000 | +12.2% | 38,998 | -0.5% | 0.70% | +30.1% |
| Q3 2014 | $2,979,000 | -6.2% | 39,208 | -2.8% | 0.54% | +4.3% |
| Q2 2014 | $3,177,000 | +4.3% | 40,358 | -0.7% | 0.51% | +2.8% |
| Q1 2014 | $3,047,000 | -4.5% | 40,633 | -1.7% | 0.50% | -5.1% |
| Q4 2013 | $3,191,000 | +9.2% | 41,333 | -1.9% | 0.53% | -6.1% |
| Q3 2013 | $2,921,000 | +5.6% | 42,125 | -3.6% | 0.56% | -7.9% |
| Q2 2013 | $2,766,000 | – | 43,700 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |